| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.694 | 10.523 | 11.215 | 2.922 | 12.832 | 8.494 | 8.649 | 6.771 | 8.098 | 9.640 |
| Total Income - EUR | 17.794 | 14.552 | 11.215 | 2.922 | 12.832 | 8.494 | 8.771 | 6.771 | 8.098 | 9.640 |
| Total Expenses - EUR | 15.714 | 13.941 | 14.745 | 6.653 | 5.506 | 6.466 | 6.643 | 6.694 | 8.004 | 9.263 |
| Gross Profit/Loss - EUR | 2.080 | 611 | -3.530 | -3.731 | 7.325 | 2.027 | 2.128 | 77 | 94 | 376 |
| Net Profit/Loss - EUR | 1.760 | 506 | -3.642 | -3.760 | 6.954 | 1.870 | 2.050 | 13 | 21 | 87 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dialma Medicis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.036 | 8.434 | 3.252 | 679 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.665 | 4.862 | 5.657 | 4.108 | 1.054 | 2.161 | 4.166 | 1.344 | 1.367 | 1.826 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 138 | 1.448 | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.527 | 3.414 | 5.657 | 4.075 | 1.054 | 2.161 | 4.166 | 1.344 | 1.367 | 1.826 |
| Shareholders Funds | -262 | 247 | -3.400 | -7.097 | -350 | 1.526 | 3.543 | 525 | 544 | 628 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.674 | 14.492 | 13.726 | 13.276 | 2.769 | 635 | 623 | 819 | 823 | 1.198 |
| Income in Advance | 2.747 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dialma Medicis Srl